APLI.TO APPILI THERAPEUTICS INC
$0.01▲ +0.00%
Healthcare
Other
Volume 102.3K
Avg Volume (10D) 12.4K
Key Metrics & Fundamentals
Market Cap
$1.32M
P/E Ratio
–
Div Yield
–%
52W Range
0.01 - 0.04
% vs 50 MA
-20.00%
% vs 200 MA
-43.18%
RSI-14
43.5
MACD Histogram
+0.0000
Beta (1Y vs SPY)
-1.24
Free Cash Flow
-$291,845
Gross Rev
$25,263
Gross Profit
$25,263
EBITDA
$241,257
COGS
–
Operating Exp
$974,580
Operating Income
-$949,317
EBIT
-$949,317
Pretax Income
-$1.01M
Net Income
-$1.05M
Price & Volume History
Loading chart…
Recent News
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027
TMX Newsfile · Aug 14, 2026 9:00 PM
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
GlobeNewswire · Jul 3, 2026 10:10 PM
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
GlobeNewswire · Jun 26, 2026 10:29 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See APLI.TO's money flow as a full page
Social Sentiment
No Reddit posts found for APLI.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.